- Home
- FTV vs BNTX Comparison
FTV vs BNTX Comparison
Compare FTV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTV | BNTX |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FTV | BNTX |
|---|---|---|
| Price | $54.79 | $92.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 11 |
| Target Price | $56.27 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $6,260,300,000.00 | $3,698,814,972.00 |
| Revenue This Year | N/A | $2.36 |
| Revenue Next Year | $3.02 | N/A |
| P/E Ratio | $21.30 | ★ N/A |
| Revenue Growth | ★ 36.34 | 3.70 |
| 52 Week Low | $46.34 | $81.20 |
| 52 Week High | $83.32 | $129.27 |
Technical Indicators
Market Signals| Indicator | FTV | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 32.64 |
| Support Level | $52.57 | $94.52 |
| Resistance Level | $55.75 | $97.35 |
| Average True Range (ATR) | 0.81 | 2.45 |
| MACD | 0.09 | -0.39 |
| Stochastic Oscillator | 68.71 | 3.68 |
Price Performance
Historical ComparisonAbout FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.